Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
CUDA
Cat. No.:
0225LY-0763
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
CUDA is a soluble cyclohydrolase inhibitor (IC50: 112 nM for human sEH) that selectively boosts PPAR-alpha activity, making it a useful tool for cardiovascular disease research.
Synonym:
479413-68-8; 12-(cyclohexylcarbamoylamino)dodecanoic acid; 12-(3-Cyclohexylureido)dodecanoic acid; 12-(3-cyclohexyl-ureido)-dodecanoic acid; 12-[[(cyclohexylamino)carbonyl]amino]-dodecanoic acid
CAS No.:
479413-68-8
Compound CID:
22978774
Formula:
C19H36N2O3
Formula Weight:
340.5
Specification
Targets&IC50:
sEH (human): 112 nM; sEH (mouse): 11.1 nM
Relative Density:
1.03 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
CUDA can be used in enzyme research as a potent inhibitor of soluble epoxide hydrolase (sEH) to study its role in inflammatory signaling.
Library Information
Target:
PPAR; Epoxide hydrolase
Receptor:
PPARα; sEH
Pathways:
DNA damage/DNA repair; Metabolism; Nuclear receptor signaling; Inflammation
Plate Number:
AOCL-10
Plate Location:
g10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
3.41 mg/mL; 10.01 mM
